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Na, K, and BP homeostasis in man during furosemide: Effects of
prazosin and captopril. Furosemide increases sodium (Na) and potas-
sium (K) excretion but if dietary salt is provided, a compensatory
reduction in Na and K excretion follows which restores neutral
balances within 18 to 24 hours. This compensation is not interrupted by
blockade of the renin—angiotensin—aldosterone system (RAA) alone
with captopril. Since plasma norepinephrine concentration increases
after furosemide and alpha1 adrenoreceptors can mediate enhanced
Na reabsorption, we administered prazosin (2 mg 6 hr') to six normal
volunteers consuming a daily intake of 270 mmol of Na and 75 mmol
of K, and added captopril (25 mg 6 hr') for an additional day to block
the RAA system concurrently. Furosemide (40 mg day) was given for
the last four days. Prazosin given alone before the diuretic reduced (P
<0.05) BP and plasma angiotensin II (All) concentration and increased
body weight and heart rate. However, when given with furosemide,
neither prazosin nor prazosin with captopril modified the short—term
natriuretic or kaliuretic responses to furosemide, or the ensuing com-
pensatory reductions in Na and K excretion. Accordingly, cumula-
tive balances for Na and K remained neutral over four days of
diuretic administration. Neither drug altered the renal responsiveness
to the diuretic which was assessed from the relationship between renal
Na and K excretion and diuretic elimination. Although the BP was
maintained when furosemide was given alone, when given with
prazosin and captopril, the mean BP fell by 13 5 mm Hg (P < 0.05).
In conclusion, in normal human subjects consuming a liberal salt intake,
neither the alpha1 adrenoreceptor nor the RAA systems are required for
maintenance of Na and K balances during administration of furose-
mide.
In previous studies, we found that even a large loss of fluid,
sodium (Nat) and potassium (K) induced by furosemide does
not ensure weight loss, negative salt balance, K depletion, or
a fall in blood pressure (BP) in normal human subjects [1—3].
This was explained by a precise renal compensation which
resulted in reduced excretion of fluid Na and K in the
post-diuretic period. The plasma concentrations of angiotensin
II (All), aldosterone and norepinephrine increased consistently
after furosemide. However, when captopril was used to block
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activation of the renin—angiotensin—aldosterone (RAA) system,
the pattern of fluid and electrolyte losses with furosemide were
not modified; a precise restoration of balance occurred after the
acute losses just as in the compensation phase following admin-
istration of furosemide alone [2]. Since the sympathetic nervous
system (SNS) may be critical for Na and BP homeostasis
during Na and fluid depletion in man [4, 5], and since recent
studies in animals have shown that enhanced Na reabsorption
during renal SNS activation is mediated by alpha1 adrenorecep-
tors [6—lO], we have studied the importance of these receptors
in mediating Nat, K and BP homeostasis during administra-
tion of furosemide. We administered prazosin to block alpha1
adrenoreceptors and captopril to inhibit generation of All
during furosemide administration to normal human subjects.
Methods
Six normal volunteers (five male and one female) aged 23 to
37 years participated after giving informed consent for a study
approved by the Human Subjects Investigation Committee of
the Brigham and Women's Hospital. The results were com-
pared to those obtained in a previous study (protocol 1) of six
normal subjects, matched for age and sex, who were treated
identically but received no prazosin or captopril [1]. An addi-
tional control group of four subjects received prazosin and
captopril but no diuretic; balance data are available on three of
these and BP data on four. Before starting the protocols, the
subjects were weighed and their BP and heart rate (HR)
measured while lying and after two minutes of standing. Mean
BP (MBP) was calculated as the sum of the diastolic BP and
one—third the pulse pressure. Thereafter, the subjects received
a closely regulated diet of three meals per day taken at 6 to 8
a.m., 12 to 1 p.m., and 6 to 8 p.m. This diet provided 20 mmol
day of Na and 75 mmol day' of K, and was supplemented
with five tablets of 1 g NaC! taken with each meal; the total
daily Na intake was 270 mmol. As in previous studies, fluids
were not restricted and the subjects continued their usual daily
activities, except that undue exercise and smoking were pro-
hibited. None of the subjects was taking any drugs.
After baseline blood samples were drawn, prazosin was
administered every six hours throughout the study, starting at
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Before
Change during
prazosin
MBP mm Hg lying 96.7 3.3 —3.3 1.5
standing 99.4 3.4 —6.9 ISa
fIR min' lying 68.3 2.8 +7.7 2.7a
standing 77.5 4.5 + 12.2 4.2a
Wt kg 72.9 4.8 + 1.0 0.38a
PRA ng m1' hr' 1.3 0.5 +0.4 0.8
Plasma All pg ml' 39.0 3.7 —10.8 21b
Plasma aldosterone iig dt' 22.4 3.0 —9.1 4.8
Plasma norepinephrine pg m1' 153.6 40.9 + 85.6 36.5
Plasma epinephrine pg mt' 49.0 6.4 —11.6 10.6
midnight on the first day. For the first day, the dose was 1 mg
six hours; thereafter the dose was increased to 2 mg six
hours'.
After three days of equilibration to prazosin and the regulated
diet, all urine was collected in consecutive six hours samples for
the subsequent six days; each sample was analyzed for volume,
Na, K and creatinine. Data from the first two of these days
(control days) were used to determine the basal patterns of
UNaY, UKV, and creatinine clearance (Car). During the subse-
quent four days (days six through nine), the subjects received
40mg of furosemide intravenously as a bolus injection at 8 a.m.
on days six, eight, and nine; it was given orally on day seven as
in previous protocols [1—3]. Captopril (25 mg six hours') was
given on day nine; the first dose was taken one hour before the
diuretic was administered since we had found that this blocked
the furosemide—induced rise in All [2]. Before furosemide was
given on days six, eight, and nine, an intravenous cannula was
inserted and, after 30 minutes of quiet sitting, a blood sample
was withdrawn; a second blood sample was obtained five hours
alter furosemide was given. On these same days, urine was
collected each 30 minutes for five hours after furosemide to
measure Na, K+ and furosemide concentrations.
Urine and plasma concentrations of Na, K, chloride (Cl-),
bicarbonate (HC03), albumin (Alb), creatinine, plasma renin
activity (PRA), All and aldosterone were measured as de-
scribed previously [1—3]. Plasma epinephrine and norepineph-
rifle concentrations were measured by a radioenzymatic
method [2] and furosemide was measured using a high—perform-
ance liquid chromatography technique with a fluorometric
detection system [1].
Within—subject comparisons were made by using a paired
1-test and between—group comparisons with an unpaired 1-test.
Results were judged to be statistically significant at 2 P  0.05.
Mean values SEM are presented.
Results
As shown in Table 1, there were three prominent effects of
five days of prazosin administration before any furosemide was
given: a decrease in the MPB while standing of 7%, accompa-
nied by an increase in HR of 16% and an increase in body
weight (body wt) of 1 kg. Plasma All concentration decreased
but there were no significant changes in PRA or the plasma
concentrations of aldosterone, norepinephrine or epinephrine.
One additional normal subject received the regulated diet for
five days on two separate occasions; during the second,
prazosin (1 mg six hours' for 24 hours, then 2 r.g six hours'
for four days) was administered. At 10 a.m. on day five on each
occasion, this subject received a graded intravenous infusion of
norepinephrine while he was recumbent. Norepinephrine was
infused via a Harvard motor—driven syringe at incremental
doses for five minute periods, with 10 minutes between infu-
sions. The log dose—response relationships for changes in
systolic blood pressure are shown in Figure 1. It is apparent that
the dose of norepinephrine required to raise the systolic BP by
20 mm Hg was increased during prazosin administration by
about threefold.
During the control days (four and five) before furosemide was
administered, daily rates of excretion of Na and K were 241
28 mol and 77 11 mmol, respectively. These were not
significantly different from the levels of intake, implying that
daily Na and K balances were neutral at the time that
furosemide was administered. On days six, eight, and nine of
intravenous furosemide administration, the excretion of Na
and K increased to maximal values within the first 30 minutes,
and levels greater than baseline persisted for two to four hours.
This short—term increase in Na and K excretion was not
significantly different between days six, eight, or nine and did
not differ from that found previously [1, 3]. There followed a
compensatory reduction in UNaV and UKV below levels of
intake; the magnitude of this compensation was not different on
days six, eight, and nine nor did it differ from that recorded
when furosemide was given alone [1, 3].
The pattern of renal Na excretion, in mmol six hours', is
shown in Figure 2. Panel A depicts for comparison the pattern
shown previously when furosemide was given alone [1]. It is
apparent that Na balance was neutral before furosemide on
both protocols although Na excretion tended to be lower (P =
0.05) in the period 12 midnight to 6 a.m. when prazosin was
Table 1. Effects of prazosin administered alone
Mean (±sEM) values in six subjects before drug administration and
changes recorded after five days of prazosin administration. These
measurements were made before furosemide was administered.
a P < 0.05
b P < 0.01
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Fig. 1. Individual values for one subject receiving the regulated diet
for five days without (open circles) or with (closed circles) prazosin.
Values shown are for increases in systolic BP recorded five minutes
after starting an intravenous infusion of norepinephrine at the rates
shown (log scale).
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administered (Fig. 2B). The diuretic induced a sharp increase in
UNaV on each day resulting in negative Na balance as indi-
cated by the solid shading. During the following 18 hour (the
compensation period) UNaV fell below the levels of intake,
resulting in positive Na balance, as indicated by the diagonal
shading. During administration of prazosin (panel B), each dose
of diuretic produced the same pattern of Na loss, followed by
a quantitative reduction in Na excretion in the compensation
period whether the diuretic was given during administration of
prazosin alone, or during prazosin with captopril. Accordingly,
Na balance was restored precisely within 24 hour of receiving
furosemide on each day regardless of whether prazosin
captopril was administered. Indeed, there was a tendency
toward positive cumulative Na balance by the final day (+96
43 mmol), although this was not statistically significant. With
the rather small number of subjects studied, there is the
possibility of a beta—type error [11]. Therefore, we studied the
cumulative Na balance of three normal subjects who received
the same regulated diet with prazosin and later captopril but
without any furosemide. There was the same positive trend in
Na balance (+ 118 49 mmol). The cumulative Na balance
of the subjects who received three days of furosemide alone
was +48 35 mmol. In no protocol was the cumulative Na
balance significantly different from zero on any day.
Renal K + excretion increased sharply in the six hours after
furosemide; the increase was not significantly different during
administration of furosemide alone (+ 27 2 mmol), when
furosemide was given with prazosin (+ 30 3 mmol), or with
prazosin plus captopril (+ 28 1 mmol). As on previous
studies, within two to four hours of furosemide, UKV was
reduced below levels of intake resulting in a compensatory
period in which K balance was positive [2]; this compensatory
response was unaltered by prazosin captopril. The cumula-
tive daily K balance, assessed from the difference between
K intake and excretion, averaged + 14 22 mmoles. The
cumulative K balance for the three subjects who had received
the regulated diet with prazosin and later captopril but no
furosemide was +52 30 mmoles; for those who received
three days of furosemide alone it was —9 14 mmoles. In no
protocol was the cumulative K balance significantly different
from zero on any day.
To study possible mechanisms for the compensatory re-
sponse, creatinine clearance and changes in hormones were
measured. Creatinine clearance was measured each six hours
from days three to eight, except during the six hours after the
diuretic was administered when sharp changes in urine flow rate
precluded calculating accurate clearance results. The mean Ccr
in the control days was 120 6 ml min 1.73 m2. There were
no significant differences from control values in any six hour
period during the four days of furosemide administration (aver-
age value: 129 7 ml min 1.73 m2) nor from the values
recorded previously when furosemide was given alone [1].
Before starting the protocol, the mean BP of the four subjects
who received the regulated diet with prazosin and later
captopril, but without furosemide, was 99.1 4.6 mm Hg. By
8 a.m. on day five, it had fallen by 10.1 2.4 mm Hg to 89.1
6.3 mm Hg. Over the subsequent five hours, it tended to
increase slightly (+2.9 0.8 mm Hg). By 8 a.m. on the final
day, the mean BP was 83.3 8.4 mm Hg. Over the subsequent
five hours, the mean BP did not change significantly (+2.5 1.9
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Fig. 2. Mean (± SEM) values for renal Na excretion in succeeding six
hourly periods of the day, commencing at 6:00 a.m. Before F represents
the average of two control days before furosemide was administered.
Fl to F4 represent the days of furosemide administration. A. Results
with no additional drugs; B. Results during prazosin administration with
captopril added for the last 24 hours. The horizontal broken line
indicates the level of Na intake. Solid shading shows periods of
negative Na balance and diagonal shading periods of positive Na
balance.
mm Hg). As shown in Table 2, the average MBP measured
before furosemide was similar during protocols 1 and 2. During
administration of prazosin, furosemide did not reduce MBP. In
contrast, when prazosin was combined with captopril, the MBP
fell with furosemide in each subject. The mean fall of 12.5 4.9
mm Hg was different from the rise of 2.5 1.9 mm Hg (P <
0.05) observed over the five hour period in the three control
subjects who received prazosin and captopril but no furose-
mide.
Administration of furosemide with prazosin alone or with
prazosin plus captopril raised the heart rate (Table 2). Furose-
mide increased the PRA in each protocol, and this led to a
consistent increase in plasma All concentrations after furose-
mide when given alone or with prazosin. However, captopril
prevented the rise in A!! despite a major increase in PRA. The
change in plasma aldosterone concentrations were more vari-
able. Aldosterone increased when furosemide was given alone,
but when the diuretic was given with the blockers no significant
changes were detected. The plasma norepinephrine concentra-
tion increased when furosemide was given alone or with
prazosin; norepinephrine remained high when furosemide was
B
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Table 2. Mean blood pressure, heart rate and hormone concentrations before, and changes produced five hours after furosemide
MBP HR
mm Hg min1
PRA
ng m1' hr'
All
pg mt1
Aldosterone
ng d1'
Norepinephrine
pg m1'
Epinephrine
pg mt'
Protocol 1. Furosemide alone
Before F 92.8 2.5 79.1 3.0 2.2 0.3 23.6 1.7 8.0 1.4 328.4 41.7 72.2 10.8
Change with F +0,4 2.1 +3.9 4.1 +3.8 05g +34.9 8.8 +5.6 l.8 + 132.0 473e +5.9 14.6
Protocol 2. Furosemide with prazosin
Before F 93.5 2.8 91.6 3,6a 2.2 0.3 28.0 1.6 14.1 2.5 247.2 24.3 37.6 3.8a
Change with F —0.4 3.7 +6.6 2.8 +2.3 0,3g +6.0 l.4 +3.4 3.4 + 155.0 34.5 +7.6 3.5
Protocol 2. Furosemide with prazosin and captopril
Before F 92.3 3.8 98.2 49b 12.3 4.0 20.8 2,0d 10.4 2.8 446.0 120.3 46.7 7.4
Change with F —12.5 49e + 13.0 5.6 + 15.3 6.3e +3.2 2.4 +7.4 6.1 +84.0 90.0 +25.7 0.T
Mean (±sEM) values from protocols 1 and 2 recorded while subjects were seated for 30 minutes. Before forosemide (F) refers to the mean values
recorded immediately before intravenous furosemide and change with F to the mean change recorded five hours later.
Significance of differences of values measured before F with P C compared to before F alone: a p < 0.05; b P < 0.01.
Significance of differences of values measured before F with P and C compared to before F with P: P < 0.05; d P < 0.01.
Significance of changes produced by furosemide: CJ < 0.05; P < 0.01; g P < 0.001
Table 3. Plasma electrolytes and albumin concentrations
Day6 Day8 Day9
Before F After F Before F After FBefore F After F
PNa mmol liter' 143.0 141.0 145.2 142.7 144.7 141.0
P value <0.02 <0.02 <0.005
PK mmol liter' 4.23 3.85 4.00 3.58 405b 3
P value <0.02 <0.005 <0.001
Pci mmol liter' 109.3 103.5 108.8 102.2 109.2 105.4
P value <0.005 <0.01 <0.01
PHCO3 mmol liter' 25.0 26.3 25.8 26.8 26.6a 27.4
P value NS NS NS
PAIb g d1' 4.20 4.62 4.23 4.58 4.28 4.40
P value <0.005 <0.005 <0.05
Mean (±5EM) values for plasma sodium, potassium, chloride, bicarbonate and albumin concentrations measured before and five hours after
furosemide. The P values refer to results of paired t-tests comparing before and after furosemide. a D < 0.05 b P < 0.01 comparing before
furosemide on day 6 with before furosemide on day 9, using paired t-tests
given with prazosin plus captopril. The plasma epinephrine
concentration tended to be lower during administration of
prazosin but increased with furosemide when captopril was
added to prazosin. Thus, the diuretic increased the plasma
concentrations of either norepinephrine or epinephrine in each
protocol.
The mean values for the plasma concentrations of electro-
lytes and albumin are shown in Table 3. Five hours after
furosemide, there were consistent falls in PNa, PK and pci, and
increases in PAIb, corresponding to increased rates of fluid and
electrolyte excretion. However, when data obtained before
furosemide administration on day nine are compared with
corresponding values before furosemide on day six, no signifi-
cant changes in PNa, Pc, or PAIb are apparent. In contrast, there
was a small fall in K of 0. 18 0.04 mmol liter' accompanied
by a rise in PHCO3 of 1.6 0.5 mmol liter' over these three days
of furosemide administration.
As in previous studies [1, 2] the renal excretion of furosemide
over six hours following the administration of the diuretic
averaged 43 2% of the administered dose. Neither prazosin
nor prazosin plus captopril affected renal furosemide excretion
on any of the days on which the diuretic was given intrave-
nously (15.7 1.9 mg; 18.1 1.9 mg; 17.5 2.5 mg on study
days six, eight, and nine, respectively).
The sigmoidal relationship between the rate of Na excretion
and the logarithm of the rate of furosemide excretion has been
used to assess renal responsiveness to furosemide [12]. As
shown in Figure 3, prazosin did not modify the relationships
between Na or K excretion and the log of furosemide
excretion.
Discussion
Our previous studies have identified two independent mech-
anisms which can limit Na and K depletion during diuretic
administration [1—3, 13]. The first, diuretic extinction, occurred
when furosemide was given while salt intake was restricted;
there was a progressive reduction in the diuretic responses to
repeated doses of the drug. The second, renal compensation,
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occurred when the diuretic was given during a more liberal salt
intake; there was a decrease in Na and K excretion during
the remainder of the day after the short—term response to the
diuretic was complete. In a previous study, we administered
captopril throughout the period of diuretic administration [2]
which abolished the diuretic—induced rises in plasma angioten-
sin II and aldosterone concentrations. However, neither the
acute natriuretic and kaliuretic responses nor the ensuing
reductions in Na and K excretion in the compensation period
were affected by captopril. There was a small fall in PK of 0.18
mmol liteC' over three days of furosemide administration with
prazosin without a change in the difference between K intake
and K excretion. This could represent a redistribution of K
into cells since there was an accompanying metabolic alkalosis
(PHcO3 rose by 1.6 mmol liter 1) Alternatively, it could repre-
sent occult fecal K losses (perhaps augmented by furosemide
administration) which were not assessed in these studies.
Furosemide appears to have activated the sympathetic ner-
vous system in these studies since there was a rise in the plasma
norepinephrine or epinephrine concentrations in each protocol
(Table 2). Direct recordings from renal nerves in conscious rats
have shown a 50 to 80% increase after furosemide; this change
was augmented by a high salt intake [14]. Activation of the
sympathetic nervous system can be important for regulation of
Na excretion during hypovolemia. Thus, patients with pro-
gressive autonomic failure do not reduce Na excretion even
after one week of reduced Na intake, whereas age—matched
controls achieve Na balance within four days [4, 5]. This
defect in salt conservation was not corrected by mineralcorti-
costeroids but could relate to renal denervation, since rabbits
with bilateral renal nerve section do not conserve Na normally
during dietary salt restriction [15]. Results from several studies
indicate that enhanced Na reabsorption accompanying
low—level renal nerve stimulation or intrarenal norepinephrine
infusion is blunted by inhibition of alpha1 adrenoreceptors with
prazosin [6—10, 16, 17]. In contrast, inhibition of alpha2
adrenoreceptors with yohimbine, rauwolscine or idozoxan or of
beta1 or beta2 adrenoreceptors with propranolol or atenolol
either does not change, or even potentiates, the enhanced
tubular Na reabsorption in these experiments [6—10, 16, 17].
In the present study, after five days of prazosin administra-
tion, the subjects' standing MBP had fallen by 7% and their
heart rate had increased by 15%. They were in neutral Na
balance before the diuretic was administered (Fig. 1) but at an
increased body weight of 1 kg, presumably reflecting a period of
fluid retention during the initial days of prazosin administration.
A decrease in standing BP, accompanied by little change or a
small increase in heart rate and body weight is characteristic of
the established phase of prazosin treatment for hypertension
[18, 19]. During prazosin, there were no concomitant changes in
the plasma norepinephrine and epinephrine concentrations nor
the PRA, but All concentrations decreased by about 25%
(Table 1). These results confirm previous studies of long—term
treatment with prazosin for hypertension which have revealed
little effect on PRA and catecholamine levels [18, 22]. However,
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Fig. 3. Mean values for Na excretion (A) and K excretion (B) as a function of simultaneously—measured rates of furosemide excretion (log
scale) after intravenous furosemide alone (F) or intravenous furosemide during administration of prazosin (F+P).
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the cause for the fall in plasma All concentrations without a fall
in PRA is unclear.
The combination of lower levels of All and aldosterone with
fluid retention produced by prior prazosin administration might
have potentiated the subsequent response to the diuretic.
However, diuretic responsiveness, as assessed from the rela-
tionship betwen the rates of excretion of Na and K and the
log of furosemide excretion [12], was unaltered by prazosin
(Fig. 3). Moreover, prazosin did not alter the renal compensa-
tion following the short—term diuresis. It seems unlikely that the
lack of a response to prazosin was due to inadequate alpha1
adrenoreceptor blockade, since only 0.25 mg of prazosin given
intravenously to human subjects leads to an 80% blockade of
the pressor response to alpha1 receptor agonists [21] and 13 mg
day blunts baroreflexes and cold pressor responses of hyper-
tensive patients [22]. Although the half—life of prazosin is only
2.5 to 4 hours the antihypertensive action normally persists for
about 10 hours [23, 24]. Thus, the six hour dose interval used in
our study should have blockd alpha1 adrenoreceptors through-
out the 24 hours of the day. Moreover, the pressor response to
infused norepinephrine was clearly attenuated four to six hours
after prazosin in the one subject in which it was tested (Fig. 1).
Furosemide elimination was unchanged by prazosin, which
appears to exclude a major confounding pharmacokinetic inter-
action. Finally, the lack of an effect of prazosin could not be
attributed to concurrent activation of the RAA system because
furosemide—induced increases in PRA, All and aldosterone
concentrations were unaltered by prazosin, and concurrent
administration of captopril with prazosin did not modify the
acute or compensatory responses to furosemide. We, therefore,
conclude that alpha1 adrenoreceptors do not modulate the acute
response to a loop diuretic in normal subjects receiving a liberal
salt intake, nor do they mediate the period of Na and K
retention that follows the acute diuresis. Consequently, alpha1
adrenoreceptors are not an essential part of the mechanisms
which maintain Na and K balances during diuretic adminis-
tration in these settings.
In patients with hypertension, prazosin and occasionally
captopril may cause fluid retention, perhaps because of a fall in
BP [19]. Indeed, weight gain was seen in our normal subjects
while they received prazosin (Table 1). However, the response
to the subsequent administration of furosemide was not altered
by the administration of the two blocking drugs.
Previously, we had found that the BP was maintained over a
five hour period of furosemide diuresis, even during adminis-
tration of captopril [2]. In the present study, the BP fell
consistently five hours after furosemide when the diuretic was
given with prazosin and captopril. However, the interpretation
of this result is not clear because we found previously that
captopril alone lowered BP [2], although this effect was not
detected in the three normal subjects in this study who were
also receiving prazosin.
The mechanisms which subserve reduced Na and K ex-
cretion in the post-diuretic phase, independent of alpha1 recep-
tors and the RAA system, have not been disclosed in these
studies. Short—term volume depletion can enhance proximal
fluid and Na reabsorption [25, 26] and thereby reduce distal
fluid delivery, which could limit K secretion [13]. Alterna-
tively, DeWardener [27 has proposed that diuretics evoke a
prolonged inhibition of natriuretic hormone(s) which mediate
the post-diuretic phase of renal Na retention.
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